Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma

CLOSED

This trial is active but is no longer accepting patients.

Trial Overview

Am I Eligible?

Participating US Centers

No Centers To Display

There are no active centers to display for this trial. Please call us at (888) 828-2206 and we'll help answer any questions that you may have.

Additional Information
Trial Phase

Phase 3

Trial Enrollment

364 sparks required

Trial Sponsors
  • Karyopharm Therapeutics
Trial Identifiers

Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST

;